V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10002955 | 10006314 | 0 | 55.4 | Palliative (P) | 2018-01-06 | 2018-01-18 | Cisplatin + Pemetrexed | N | N | 10454507 | CISPLATIN + PEMETREXED |
| 10002956 | 10001907 | 1.61 | 57 | Disease modification (D) | 2016-04-27 | 2016-04-27 | Hydroxycarbamide | N | N | 10454558 | HYDROXYCARBAMIDE |
| 10002957 | 10001908 | 0 | 55 | Palliative (P) | 2017-10-15 | 2017-10-17 | Hydroxycarbamide | N | N | 10454830 | HYDROXYCARBAMIDE |
| 10002958 | 10001909 | 1.67 | null | Neo-adjuvant (N) | 2013-12-30 | 2014-01-08 | ECX | N | N | 10454838 | ECX |
| 10002959 | 10006315 | 2 | 49.5 | Palliative (P) | 2018-05-15 | 2018-06-18 | Cisplatin + Pemetrexed | 2 | N | 10454889 | CISPLATIN + PEMETREXED |
| 10002960 | 10001910 | 1.88 | 82 | Curative (C) | 2015-09-04 | 2015-09-26 | EOX | 02 | N | 10454900 | EOX |
| 10002961 | 10001911 | 1.54 | 66.1 | Palliative (P) | 2016-04-25 | 2016-04-29 | Rituximab | 02 | N | 10454943 | RITUXIMAB |
| 10002962 | 10001912 | 1.72 | 81 | Neo-adjuvant (N) | 2017-12-26 | 2017-12-30 | ECX | 02 | N | 10454967 | ECX |
| 10002963 | 10006316 | 1.56 | 58.9 | Curative (C) | 2017-12-05 | 2017-12-05 | CVP R | 02 | N | 10454979 | CVP R |
| 10002964 | 10001913 | 1.54 | 58.9 | Palliative (P) | 2014-05-20 | 2014-06-10 | PEMBROLIZUMAB | 2 | N | 10455052 | PEMBROLIZUMAB |
| 10002965 | 10001914 | null | 0 | Palliative (P) | 2016-07-21 | 2016-07-22 | R GCVP | N | null | 10455095 | CVP R |
| 10002966 | 10001915 | 1.56 | 39.1 | Palliative (P) | 2017-10-30 | 2017-10-31 | Hydroxycarbamide | 2 | N | 10455140 | HYDROXYCARBAMIDE |
| 10002967 | 10001915 | 1.73 | 54.2 | Adjuvant (A) | 2015-11-03 | 2015-11-17 | CISPLATIN + VINORELBINE | 2 | N | 10455140 | CISPLATIN + VINORELBINE |
| 10002968 | 10001916 | null | 82.1 | Palliative (P) | 2014-10-11 | 2014-10-17 | Carboplatin + Vinorelbine Oral | N | N | 10455351 | CARBOPLATIN + VINORELBINE |
| 10002969 | 10001916 | 1.78 | 0 | Palliative (P) | 2018-04-02 | 2018-04-15 | Carboplatin + Vinorelbine Oral | 02 | N | 10455351 | CARBOPLATIN + VINORELBINE |
| 10002970 | 10001917 | 1.66 | 41.2 | Disease modification (D) | 2018-08-20 | 2018-08-26 | R GCVP | N | N | 10455392 | CVP R |
| 10002971 | 10001917 | 1.78 | 72.4 | Disease modification (D) | 2015-06-01 | 2015-11-18 | Rituximab | null | N | 10455392 | RITUXIMAB |
| 10002972 | 10001918 | 1.72 | 86 | Palliative (P) | 2014-04-27 | 2014-05-21 | Enzalutamide | 02 | N | 10455484 | ENZALUTAMIDE |
| 10002973 | 10001918 | 1.52 | 44 | Palliative (P) | 2015-11-07 | 2015-12-11 | CVP R | N | N | 10455484 | CVP R |
| 10002974 | 10001919 | null | 66.2 | Disease modification (D) | 2019-01-18 | 2019-01-27 | Rituximab | N | null | 10455691 | RITUXIMAB |
| 10002975 | 10001920 | null | 60.4 | Neo-adjuvant (N) | 2017-04-01 | 2017-04-03 | EOX | null | N | 10455693 | EOX |
| 10002976 | 10006321 | 1.79 | 82 | Disease modification (D) | 2017-01-30 | 2017-02-05 | CVP R | N | N | 10455849 | CVP R |
| 10002977 | 10001921 | null | 43.8 | Palliative (P) | 2016-06-06 | 2016-06-06 | Carboplatin + Vinorelbine Oral | 2 | N | 10455859 | CARBOPLATIN + VINORELBINE |
| 10002978 | 10001922 | 1.47 | 43.8 | Palliative (P) | 2017-06-25 | 2017-06-25 | CISPLATIN + VINORELBINE | 2 | N | 10455903 | CISPLATIN + VINORELBINE |
| 10002979 | 10001923 | 1.78 | 93.4 | Palliative (P) | 2014-08-17 | 2014-09-05 | Cisplatin + Pemetrexed | 2 | N | 10455910 | CISPLATIN + PEMETREXED |
| 10002980 | 10001924 | null | 115.3 | Curative (C) | null | 2018-03-03 | GEMCITABINE | null | null | 10455937 | GEMCITABINE |
| 10002981 | 10001925 | 1.78 | 71.2 | Palliative (P) | 2015-10-06 | 2015-10-09 | CVP R | N | N | 10455985 | CVP R |
| 10002982 | 10001925 | 1.56 | 83.2 | Palliative (P) | 2017-07-29 | 2017-08-07 | Enzalutamide | N | N | 10455985 | ENZALUTAMIDE |
| 10002983 | 10001926 | 1.75 | 83.2 | null | 2017-04-10 | 2017-04-22 | Rituximab | N | null | 10456193 | RITUXIMAB |
| 10002984 | 10001926 | null | 72 | Palliative (P) | 2018-11-06 | 2018-11-18 | PEMBROLIZUMAB | N | N | 10456193 | PEMBROLIZUMAB |
| 10002985 | 10001927 | 1.51 | null | Palliative (P) | 2017-12-30 | 2018-02-03 | Trial Unspecified | 01 | N | 10456469 | TRIAL |
| 10002986 | 10001928 | 0 | 76.8 | Palliative (P) | 2016-06-04 | 2016-06-21 | ECX | 02 | N | 10456510 | ECX |
| 10002987 | 10001929 | 1.7 | 95 | Palliative (P) | 2016-11-04 | 2016-11-15 | EOX | 02 | N | 10456556 | EOX |
| 10002988 | 10001929 | 1.69 | 124 | Palliative (P) | 2016-12-09 | 2016-12-29 | CISPLATIN + VINORELBINE | 02 | null | 10456556 | CISPLATIN + VINORELBINE |
| 10002989 | 10001930 | 1.82 | 72.5 | Disease modification (D) | 2018-11-18 | 2018-11-18 | Hydroxycarbamide | N | N | 10456604 | HYDROXYCARBAMIDE |
| 10002990 | 10001931 | 1.8 | null | Palliative (P) | 2018-04-18 | 2018-04-25 | PEMBROLIZUMAB | 02 | N | 10456669 | PEMBROLIZUMAB |
| 10002991 | 10001932 | 1.75 | 70.9 | Palliative (P) | 2016-02-03 | 2016-02-05 | Enzalutamide | N | N | 10456694 | ENZALUTAMIDE |
| 10002992 | 10001933 | 1.74 | null | Disease modification (D) | 2017-09-03 | 2017-09-08 | Enzalutamide | 02 | N | 10456717 | ENZALUTAMIDE |
| 10002993 | 10001934 | null | 56.4 | Curative (C) | 2017-05-03 | 2017-05-06 | Cisplatin + Vinorelbine (PO) | N | N | 10456760 | CISPLATIN + VINORELBINE |
| 10002994 | 10001935 | 1.83 | 54.7 | Palliative (P) | 2017-07-12 | 2017-07-25 | PEMBROLIZUMAB | N | N | 10456773 | PEMBROLIZUMAB |
| 10002995 | 10001935 | 0 | 0 | Curative (C) | null | 2017-04-30 | CVP R | N | N | 10456773 | CVP R |
| 10002996 | 10001936 | null | 0 | Adjuvant (A) | 2016-01-16 | 2016-02-13 | Cisplatin + Vinorelbine (IV) | N | null | 10456880 | CISPLATIN + VINORELBINE |
| 10002997 | 10006326 | 1.81 | 95 | Palliative (P) | 2015-04-03 | 2015-04-08 | R GCVP | N | N | 10456918 | CVP R |
| 10002998 | 10006326 | 1.47 | 48.65 | Adjuvant (A) | 2018-01-22 | 2018-01-28 | Cisplatin + Vinorelbine (IV) | 02 | N | 10456918 | CISPLATIN + VINORELBINE |
| 10002999 | 10001937 | 1.61 | 73.4 | null | 2018-04-21 | 2018-05-02 | Rituximab | 02 | N | 10457089 | RITUXIMAB |
| 10003000 | 10001938 | 1.58 | 49.5 | Curative (C) | 2018-01-07 | 2018-01-07 | Gemcitabine weekly | N | N | 10457124 | GEMCITABINE |
| 10003001 | 10001939 | 1.8 | 0 | Palliative (P) | 2018-10-28 | 2018-10-30 | PEMBROLIZUMAB | 02 | N | 10457164 | PEMBROLIZUMAB |
| 10003002 | 10001939 | 0 | 106 | Adjuvant (A) | 2016-02-07 | 2016-03-04 | Trial Unspecified | 02 | N | 10457164 | TRIAL |
| 10003003 | 10008040 | 1.71 | 0 | Palliative (P) | 2017-10-21 | 2017-10-28 | EOX | N | N | 10457238 | EOX |
| 10003004 | 10008040 | 0 | 67.8 | Disease modification (D) | 2014-06-24 | 2014-06-24 | CVP R | 02 | N | 10457238 | CVP R |